Call for Abstracts

The AIDS Vaccine Conference invites you to submit a late breaker abstract in the following topics. Abstract submission opens on Monday August 18th and will close on Friday August 29th. Submitters will be notified of their status by Thursday Septemeber 18th.
IMPORTANT NOTE: Accepted authors must register for the Conference by September 30th to participate in the Program.

AIDS 2008 Abstract Topics

  • Acute HIV Infection
  • Adjuvants
  • Animal Model Development
  • B Cell Immunology and Neutralizing Antibodies
  • B Cell Vaccine Concepts and Design
  • Clinical Trial Site Development
  • HIV Transmission
  • Host Genetic Factors
  • Immune Escape
  • Innate Immunity
  • Mucosal Immunity
  • Novel Immunogens/Inserts
  • Prevention of HIV in Children
  • Prophylactic Vaccine Trials
  • Social/Ethical/Access/Regulatory Issues
  • T Cell Immunity
  • T Cell Vaccine Concepts and Design
  • Therapeutic Vaccine Trials
  • Vaccine and Microbicide Platforms
  • Viral Diversity

Abstract Submission Opens: March 10, 2008
Abstract Deadline: May 11, 2008 at midnight PST (GMT -7)
Late Breaker Abstract Submission Opens: August 18, 2008
Late Breaker Abstract Deadline : August 29, 2008 at 17h00 GMT -7

Abstract Submission

Click here to submit your late breaker abstract now.

Submission Guidelines

Individuals submitting abstracts agree that if their abstract is accepted, they will attend the meeting and present their abstract as scheduled. The presenting author should be able to answer substantive questions about all aspects of their study.

Once an abstract has been accepted and scheduled, it cannot be withdrawn. Authors agree to have the abstract published in the 2008 Conference Materials and online as a dedicated supplement to AIDS Research and Human Retroviruses. The supplement will be published during the week of the Conference and will be available online for free. Late breaker abstracts will not be published online.

General Policies

  • Authors are permitted to submit an unrestricted number of abstracts.
  • Abstracts must be submitted in English.
  • Notifications of acceptance will be sent to the presenting authors in June 2008. Scheduling details and instructions for oral and poster presentations will be included in this correspondence.
  • Authors whose abstracts are accepted must register for the Conference by 11 July 2008.
  • Only the name of the presenting author will appear in the final conference program.
  • Previously published abstracts should not be submitted.
  • Submissions not conforming to established guidelines will not be reviewed.
  • All accepted abstracts will be published.

On-Line Abstract Submission

Abstracts must be submitted via the on-line submission system on this web site. Submitters will be prompted through the electronic submission process.

Click here to view a checklist of the information needed for abstract submission.

Please carefully review the abstract prior to its submission. Note that if an abstract has been entered but the “Save and Complete” button has not been clicked, it is not considered as complete and will not be reviewed. Edits to the abstract (other than designating a different category) may be made online after submission up until the deadline of 17:00 GMT - 7, May 7, 2008. Editing a submitted abstract requires use of the abstract ID number that you will receive by email after you have completed the submission process (see Notification and Correspondence, below). You may only have one incomplete abstract at a time. You can not start a second abstract without completing and submitting the first.

Published Abstracts

Accepted abstracts will be published in the AIDS Vaccine 2008 Abstract Book and distributed to registrants. Abstracts will also be published online as a dedicated supplement to AIDS Research and Human Retroviruses. The supplement will be published during the week of the Conference and will be available online for free. Late breaker abstracts will not be published online.

By submitting an abstract, authors and co-authors transfer any copyrights and grant permission to AIDS Vaccine 2008 to audio/video record oral presentations.

Abstract Selection Process

Abstract submissions will be peer reviewed by the Conference Organizers and members of the Scientific Organizing Committee. To minimize subjectivity in the scoring process, any reviewer with a conflict of interest (as defined by NIH rules, e.g., co-authorship, financial interest, or scientific/personal conflict with the authors that could affect objectivity of scoring) will be excluded from scoring or discussing the abstract in question. In the final rankings, mean score and standard deviation will be calculated, and the reviewers' scores will be anonymous. Abstract acceptance is based upon abstract quality, the potential significance of the observations, and the rigor with which the scientific methods were applied. Further, the Conference Organizers consider thematic balance in determining which abstracts will be presented orally.

Late Breaker Abstracts

Only abstracts containing novel, cutting-edge information will be considered. Late Breaker abstracts must be submitted online. Late Breaker online submission will open August 18, 2008. The deadline for Late Breaker abstract submission is 17:00 GMT-7 on August 29, 2008. Due to the limited number of Conference time slots and the nature of late breakers, very few submissions will be accepted for oral presentations only.

Poster Specifications

Poster Printing

The Cape Town Internaitonal Convention Centre has a printing company located onsite that can print your poster for you and have it ready to pick up upon your arrival. To utilize this service, email your poster specifications and requirements to Carnita at [email protected] at least 48 hours in advance. For questions contact:
Carnita Manie
[email protected]

Presentation Requirements

  • All posters must be set up on Monday, 13 October between 12:00 and 16:00 (push pins will be provided onsite).
  • All posters will be up for the duration of the meeting.
  • The posters will be on display during the opening cocktail function.
  • At least one of the authors must be present at the assigned poster during the official poster presentation session on Wednesday 15 from 18:00 – 20:00. If you are unable to present your poster, please make arrangements for one of your co-authors to present. Refreshments will be offered during the session.
  • There will be up to four parallel poster discussion groups (for those selected in particular topics) on Tuesday 14 from 13:30 – 14:30. If chosen, you will be asked to present your poster with no more than two PowerPoint slides.
  • Individual handouts relative to poster presentations are popular and encouraged.
  • All posters should be removed after the close of the meeting on Thursday 16 October. The poster hall will remain open on Thursday, until 18:00. Posters not removed by this time will be discarded.

Format Requirements

  • Poster presentation space is A0 size (portrait or landscape) or 4' x 4' (121.92cm x 121.92cm).
  • Poster should be easily read at a distance of 5 feet (see Components and Design of a Poster below for font sizes).
  • A poster printed on one large sheet of matte or semi-gloss paper is encouraged.
  • Layout:

    Include the title of the presentation in large letters, the authors' names, and the institution(s) where the work was completed at the top center of the poster. Poster numbers will be provided onsite. Poster numbers will be posted above your poster; you do not need to leave room for your poster number. A reproduction of the abstract placed in the upper left side of the poster is suggested as are the Introduction and Summary/Conclusions sections of your poster.

  • Double space lines of text.
  • Only text, graphs, photographs, and artwork may be placed on the poster board.

Components and Design of the Poster

The heading comprises a title for the research project, author names, and author affiliations (including city, state, and country). Headings have more impact in a sans serif font such as Helvetica or Arial.

  1. Title (no smaller than 72 points, preferably in a sans serif font)
  2. Author names (no smaller than 36 points, preferably in a sans serif font)
  3. Affiliations (no smaller than 26 points, preferably in a sans serif font)
Abstract:
The abstract summarizes the main results succinctly.
Body:
The body text of the poster will describe background, methodology, results, and interpretation. Body text should be no smaller than 16 points and preferably in a serif font such as Times New Roman or Garamond.
Graphics:
The graphics are essential for an effective poster. Include captions below each graphic. Captions for graphics should be no smaller than 14 points and preferably in a serif font. Graphics should be understandable without recourse to a detailed text caption.
Conclusions:
Conclusions should be clear and succinct and provide "take home" messages.

Download PDF of Poster Presentation Guidelines

© 2005 Global HIV Vaccine Enterprise